Select your Market

Africa
- Algeria
- Angola
- Benin
- Botswana
- Burkina Faso
- Burundi
- Cameroon
- Cape Verde
- Central African Republic
- Chad
- Comoros
- Congo
- Congo Democratic Republic
- Djibouti
- Egypt
- Equatorial Guinea
- Eritrea
- Ethiopia
- Gabon
- Gambia
- Ghana
- Guinea
- Guinea-Bissau
- Ivory Coast
- Kenya
- Lesotho
- Liberia
- Libya
- Madagascar
- Malawi
- Mauritania
- Mauritius
- Morocco
- Mozambique
- Namibia
- Niger
- Nigeria
- Reunion Islands
- Rwanda
- Saint Helena
- São Tomé and Príncipe
- Senegal
- Seychelles
- Sierra Leone
- Somalia
- South Africa
- Sudan
- Swaziland
- Tanzania
- Togo
- Tunisia
- Uganda
- Zambia
- Zimbabwe
Asia
- Bahrain
- Bangladesh
- China, mainland
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kuwait
- Lebanon
- Malaysia
- Oman
- Palestine
- Philippines
- Qatar
- Saudi Arabia
- Singapore
- South Korea
- Syria
- Taiwan
- Thailand
- Turkey
- United Arab Emirates
- Vietnam
- Yemen
Europe
- Albania
- Austria
- Baltic Region
- Belarus
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Netherlands
- North Macedonia
- Norway
- Poland
- Portugal
- Romania
- Russian Federation
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Türkiye
- Ukraine
- United Kingdom
Latin America
- Argentina
- Aruba
- Bahamas
- Barbados
- Belize
- Bolivia
- Brazil
- Central America
- Chile
- Colombia
- Costa Rica
- Cuba
- Curacao-NL Antillen
- Ecuador
- El Salvador
- Guatemala
- Haiti
- Honduras
- Jamaica
- Mexico
- Nicaragua
- Panama
- Paraguay
- Perú
- República Dominicana
- Trinidad and Tobago
- Uruguay
- Venezuela
North America
- Canada
- United States of America
Oceania
- Australia
- New Zealand

Press Release Archive

Browse our collection of press releases and company news from recent years.

January
- 02 January 2023 - Merck KGaA, Darmstadt, Germany Completes Acquisition of the Chemical Business of Mecaro
February
- 08 February 2023 - Semiconductor Solutions
- 13 February 2023 - New Analyses Reinforce Survival Benefit of BAVENCIO First-Line Maintenance Treatment in Patients With Advanced Urothelial Carcinoma
- 20 February 2023 - EMD Electronics to Showcase Expertise at 2023 SPIE Advanced Lithography & Patterning
- 23 February 2023 - ACTRIMS Forum 2023
March
- 02 March 2023 - Financial Results 2022
- 09 March 2023 - Semiconductor Manufacturing
- 22 March 2023 - Merck KGaA, Darmstadt, Germany at the European Coatings Show 2023 in Nuremberg
- 23 March 2023 - Merck KGaA, Darmstadt, Germany Presents its Latest Cosmetics Innovations at “in-cosmetics” 2023
- 27 March 2023 - Merck KGaA, Darmstadt, Germany Announces Expanded Partnership with Beyond Benign to Increase Global Access
- 27 March 2023 - Merck KGaA, Darmstadt, Germany Strengthens Oncology Franchise
April
- 12 April 2023 - Significant Investment in the World’s Largest Integrated Specialty Gases Facility
- 12 April 2023 - Initiation of New Patients on Evobrutinib Paused in the U.S.
- 24 April 2023 - Merck KGaA, Darmstadt, Germany Launches Ultimus Film to Offer Superior Strength and Leak Resistance
- 26 April 2023 - Curiosity Cube
- 28 April 2023 - Annual General Meeting Approves all Agenda Items
May
June
- 06 June 2023 - Merck KGaA, Darmstadt, Germany Announces Proteologix as Winner of its North American Advance Biotech Grant
July
- 11 July 2023 - Future Insight Prize 2023 Awarded to Khalid Salaita for Early Detection of Pandemics
- 11 July 2023 - U.S. Businesses of Merck KGaA, Darmstadt, Germany, Named a “Best Place to Work (...)
- 12 July 2023 - Lenexa, Kansas L3 Expansion PR
August
- 03 August 2023 - Q2 2023: Demonstrating Resilience under Market Pressure
September
- 13 September 2023 - Fertility Benefits
- 20 September 2023 - AI Partnerships in Healthcare
- 26 September 2023 - Merck KGaA, Darmstadt, Germany to Become First Provider to Offer Fully Integrated mRNA Services
October
- 05 October 2023 - Embracing Carers UN Collaboration
- 10 October 2023 - Merck KGaA, Darmstadt, Germany Releases Its First-Ever DE&I Report
- 11 October 2023 - EMD Electronics Celebrates Opening of New Arizona Factory
- 11 October 2023 - Merck KGaA, Darmstadt, Germany Presents New Evobrutinib Data at the 9th Joint ECTRIMS-ACTRIMS congress in Milan
- 16 October 2023 - Merck KGaA, Darmstadt, Germany to Present Latest Research from Oncology Portfolio at ESMO
- 19 October 2023 - Merck KGaA, Darmstadt, Germany to Return to Growth during Fiscal 2024
- 30 October 2023 - Merck KGaA, Darmstadt, Germany Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui
November
- 02 November 2023 - Merck KGaA, Darmstadt, Germany VPPAs for Europe
- 09 November 2023 - Merck KGaA, Darmstadt, Germany Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3
- 14 November 2023 - Merck KGaA, Darmstadt, Germany Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District
- 21 November 2023 - Merck KGaA, Darmstadt, Germany Expands Newest Biologics Testing Center in Shanghai
- 28 November 2023 - Merck KGaA, Darmstadt, Germany and p-Chip close the gap between physical and digital trust layers
December
- 04 December 2023 - Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko
- 05 December 2023 - Merck KGaA, Darmstadt, Germany Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis
- 06 December 2023 - Merck KGaA, Darmstadt, Germany Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation
- 06 December 2023 - Merck KGaA, Darmstadt, Germany Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis
- 14 December 2023 - Merck KGaA, Darmstadt, Germany’s material intelligence takes center stage at CES 2024
- 15 December 2023 - EMA’s CHMP Positive for Arpraziquantel to Treat Schistosomiasis in Preschool-Aged Children

By {{ authorText(item) }}

{{ item.publicationDate }}

January
- 06 January 2022 - Definitive Agreement to Acquire Exelead
- 10 January 2022 - Merck Announces Out-licensing Agreement for Osteoarthritis Asset Sprifermin
- 11 January 2022 - EMD Electronics Announces New Factory in Arizona
- 13 January 2022 - Merck KGaA, Darmstadt, Germany Announces New Appointments in Global R&D and Strategy Leadership for Healthcare
- 20 January 2022 - Elevian announced as Winner of North American Advance Biotech Grant
- 24 January 2022 - 1.5 Billionth Tablet of Praziquantel donated
February
- 07 February 2022 - Merck KGaA, Darmstadt, Germany Announces Organizational Transformation of Life Science Business
- 07 February 2022 - Launch of New Cosmetics Ingredients Inspired by Superfoods
- 18 February 2022 - Tepmetko-EC-Approval
- 18 February 2022 - Bavencio ASCO GU
- 24 February 2022 - New MAVENCLAD® Data at ACTRIMS Forum 2022
March
- 03 March 2022 - Results of the Fourth Quarter and Fiscal Year 2021
- 23 March 2022 - Merck KGaA, Darmstadt, Germany Completes Acquisition of Exelead
April
- 05 April 2022 - Acquisition of MAST® Platform
- 14 April 2022 - ZooMAb® Antibodies Earns ACT Label
- 20 April 2022 - Heinrich Emanuel Merck Award 2022
- 22 April 2022 - Annual General Meeting: Approval of all Agenda Items
- 28 April 2022 - Merck KGaA, Darmstadt, Germany Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China
May
- 02 May 2022 - New Head of Inhouse Consulting
- 06 May 2022 - Science Based Targets initiative
- 12 May 2022 - Quarterly Statement Q1/2022
- 18 May 2022 - Curiosity Cube® Mobile Lab
- 23 May 2022 - Investment in Manufacturing Expansion - Cork, Ireland
- 23 May 2022 - Emanuel Merck Lectureship 2022
- 26 May 2022 - Merck KGaA, Darmstadt, Germany to Present Latest Research From Oncology Portfolio at ASCO 2022
June
- 03 June 2022 - Development Programs in Oncology
- 08 June 2022 - Merck KGaA, Darmstadt, Germany Places Bonds Amounting to €1.0 billion
- 14 June 2022 - Collaboration with Agilent Technologies
- 14 June 2022 - Collaboration in Machine Learning Project
- 23 June 2022 - CDMO Facility to Address Demand for Critical Cancer Therapies
July
- 13 July 2022 - Future Insight Prize 2022
- 14 July 2022 - Modular Automation for Laboratories
- 18 July 2022 - New Solar Panels at Merck’s Wisconsin, USA Site Add Renewable Energy to Power Grid
- 19 July 2022 - Company’s First Lateral Flow Membrane Production Facility in the United States
August
- 03 August 2022 - Collaboration for more sustainable gas solutions
- 04 August 2022 - Q2 2022: Merck Delivers Robust Growth Despite Headwinds
- 09 August 2022 - Merck KGaA, Darmstadt, Germany Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform
- 17 August 2022 - Merck KGaA, Darmstadt, Germany to acquire chemical business of Mecaro
September
- 07 September 2022 - New Chief Human Resources Officer
- 08 September 2022 - Expansion Molsheim
- 08 September 2022 - ESMO 2022 Curtain Raiser
- 08 September 2022 - ESMO 2022 Xevinapant
- 21 September 2022 - Biologics Testing Center Shanghai
- 21 September 2022 - Nerviano Collaboration
- 28 September 2022 - Digital Color Measurement
October
- 04 October 2022 - Millipore CTDMO Services in Martillac
- 06 October 2022 - Capital Markets Day 2022
- 21 October 2022 - "Hall of Fame der deutschen Forschung"
- 26 October 2022 - New Data for Evobrutinib
- 26 October 2022 - MS Portfolio at ECTRIMS
- 27 October 2022 - Digital twin solution for Primary Packaging
November
- 05 November 2022 - Launch new cosmetics ingredients
- 07 November 2022 - Biotheus
- 10 November 2022 - Merck KGaA, Darmstadt, Germany Confirms Guidance for 2022 and Delivers Strong Organic Growth in Q3
- 17 November 2022 - Merck KGaA, Darmstadt, Germany Invests € 290 Million in U.S. Drug Safety Testing Capacity
- 21 November 2022 - RD Update Call
December
- 02 December 2022 - European Medicines Agency (EMA) Validates Application for Arpraziquantel
- 06 December 2022 - Merck KGaA, Darmstadt, Germany Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
- 13 December 2022 - Merck KGaA, Darmstadt, Germany Signs MoU with Synplogen
- 15 December 2022 - Merck KGaA, Darmstadt, Germany to showcase technologies and applications at CES 2023
- 20 December 2022 - Merck KGaA, Darmstadt, Germany Announces Collaboration With Mersana Therapeutics

January
- 01 January 2021 - Update on the INTR@PID Clinical Program Including Lung 037 Study
- 07 January 2021 - Merck KGaA, Darmstadt, Germany Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
- 08 January 2021 - Digital-Ethics-Advisory-Panel
- 25 January 2021 - Bavencio 1L UC EU Approval
- 26 January 2021 - Wolfgang Losert to retire
- 28 January 2021 - 2020 State of Curiosity Report
February
- 02 February 2021 - Merck KGaA, Darmstadt, Germany Enhances Design for Sustainability Framework, Offers Customers Data-Drive
- 02 February 2021 - Merck KGaA, Darmstadt, Germany and BioNTech Extend Strategic Partnership
- 03 February 2021 - FDA Approves TEPMETKO
- 04 February 2021 - North American Leadership Change in HC
- 04 February 2021 - Merck KGaA, Darmstadt, Germany Continues Commitment to Science Education and Equity with Leading Non-Profits
- 09 February 2021 - Purchase of facility in Arizona
- 09 February 2021 - Merck KGaA, Darmstadt, Germany Mourns Hans Joachim Langmann
- 12 February 2021 - Merck KGaA, Darmstadt, Germany Establishes External Expert Committee for Sustainability
- 16 February 2021 - Embracing Carers
- 24 February 2021 - TINS-Neuroscience
- 25 February 2021 - Merck KGaA, Darmstadt, Germany to Manufacture Next-Generation Biotherapeutics for Alteogen
- 25 February 2021 - New analysis from the MAGNIFY-MS study on MAVENCLAD® in patients with RMS
March
- 01 March 2021 - Xevinapant
- 04 March 2021 - Performance Materials Is Now Electronics
- 04 March 2021 - Merck KGaA, Darmstadt, Germany Reports Record Results in a Turbulent Year
- 10 March 2021 - Merck KGaA, Darmstadt, Germany Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement
- 16 March 2021 - Merck KGaA, Darmstadt, Germany Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment
- 17 March 2021 - Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Therapies
- 29 March 2021 - Merck KGaA, Darmstadt, Germany Announces Commercial Launch of Liquid Crystal-Based Solution for Smart Antennas
April
- 12 April 2021 - Merck KGaA, Darmstadt, Germany Advances ATR Inhibitor Berzosertib in Small Cell Lung Cancer
- 13 April 2021 - Sustainability Report 2020
- 14 April 2021 - Merck KGaA, Darmstadt, Germany and TU Darmstadt Extend Strategic Research Collaboration
- 15 April 2021 - Merck KGaA, Darmstadt, Germany Announces Investment of EUR 20 million to Expand its Site in Shizuoka, Japan
- 16 April 2021 - Evobrutinib to Demonstrate Reduction of a Key Biomarker
- 23 April 2021 - New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD® Use
- 23 April 2021 - Annual General Meeting: Shareholders Approve all Agenda Items
- 27 April 2021 - Merck KGaA, Darmstadt, Germany strengthens business model for Surface Solutions in the Nordics
May
- 03 May 2021 - Merck KGaA, Darmstadt, Germany Statement on the Out-licensing Agreement for Investigational sonelokimab (M1095)
- 04 May 2021 - Merck-news-04-05-2021
- 12 May 2021 - First Quarter of 2021: Great Strength in Challenging Market Environment
- 17 May 2021 - Merck KGaA, Darmstadt, Germany and BioMed X Institute Extend Collaboration
- 18 May 2021 - Merck KGaA, Darmstadt, Germany Announces Changes in Operating Model for Healthcare Business Sector
- 19 May 2021 - Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO
- 26 May 2021 - Accelerates Scale Up of Lipids
- 27 May 2021 - Cultured Meat - Research Grants
- 31 May 2021 - Personnel changes to further push science & technology based strategic growth trajectory
June
- 10 June 2021 - Merck KGaA, Darmstadt, Germany receives Halal certifications for cosmetics effect and care solutions portfolio
- 29 June 2021 - Bioelectronics BBraun Neuroloop
July
- 08 July 2021 - Bioelectronics Inbrain
- 13 July 2021 - Future Insight Prize 2021
- 15 July 2021 - Merck KGaA, Darmstadt, Germany and Universal Agree on Contract Manufacturing for new Pediatric Medication Against
- 19 July 2021 - Investments Darmstadt Site
- 22 July 2021 - Merck KGaA, Darmstadt, Germany Launches New Green Solvents for Photoresist Removal in Chip Production
- 23 July 2021 - Merck KGaA, Darmstadt, Germany Announces Appointment of Head of China & International for Healthcare
- 29 July 2021 - Merck KGaA, Darmstadt, Germany and TU Darmstadt support four visionary sustainability projects
August
- 05 August 2021 - New Statutory Auditor
- 05 August 2021 - Strong Second Quarter with Double-Digit Growth Driven by Big 3
- 06 August 2021 - Changes in the leadership team of Electronics
- 23 August 2021 - Company Statement Bintrafusp Alfa
- 25 August 2021 - Merck KGaA, Darmstadt, Germany Announces Change in IT Leadership
September
- 07 September 2021 - Smart Antenna
- 09 September 2021 - Capital Markets Day 2021
- 13 September 2021 - ESMO 2021 Curtain Raiser
- 16 September 2021 - New Group Function Sustainability
- 20 September 2021 - Electronics invests in growth
- 21 September 2021 - Merck KGaA, Darmstadt, Germany opens second production line for silica-based effect pigments in Gernsheim
- 22 September 2021 - Sabia Schwarzer Appointed Head of Group Communications, Brand and Corporate Affairs
- 29 September 2021 - Leadership Changes Group Level
- 30 September 2021 - Merck KGaA, Darmstadt, Germany Announces Mutual Decision to End Bintrafusp Alfa Agreement with GSK
October
- 04 October 2021 - Enrolment of Evobrutinib Phase III Clinical Trials
- 05 October 2021 - Merck KGaA, Darmstadt, Germany Licenses Foundational CRISPR Technology to Cellecta, Paving Path for Development of Next-Generation Treatments
- 10 October 2021 - Siemens and Merck Collaborate to Boost Machine-to-Machine Trust in Industrial Value Chains
- 11 October 2021 - Launch of-Ronacare® Epintegrity
- 12 October 2021 - New Viral Vector Manufacturing Facility for Gene Therapy
- 13 October 2021 - New Real-World MAVENCLAD® Data Show
- 14 October 2021 - Evobrutinib-Significant-Reduction-in-Slowly-Expanding-Lesions-in-Patients-with-RMS
- 21 October 2021 - Özlem Türeci and Uğur Şahin Inducted into the “Hall of Fame der deutschen Forschung”
- 28 October 2021 - Merck KGaA, Darmstadt, Germany Drives New Innovation & Adds Capacity
November
- 03 November 2021 - Merck KGaA raises forecast for full year 2021
- 10 November 2021 - New Study Identifies Drivers of Scientific Research Productivity
- 11 November 2021 - Q3 2021: “Big 3” Again Deliver Efficient, Double-Digit Growth
- 16 November 2021 - Phase III Results for Arpraziquantel
- 16 November 2021 - Merck KGaA, Darmstadt, Germany Announces New Sector CFO Healthcare
- 18 November 2021 - Katherine Dei Cas Appointed to SEMI North America Advisory Board
- 22 November 2021 - Novel Mechanisms with the Potential to Transform
December
- 07 December 2021 - Athinia to Accelerate the Use of AI and Big Data to Solve Critical Semiconductor Challenge
- 07 December 2021 - EMD Electronics Announces $1 Billion Investment in US to Support Semiconductor Customers
- 08 December 2021 - Merck KGaA, Darmstadt, Germany Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million
- 09 December 2021 - Merck KGaA, Darmstadt, Germany to Lead BAIQO Quantum Computing Project
- 12 December 2021 - Acquisition-of-Chord-Therapeutics
- 13 December 2021 - Merck KGaA, Darmstadt, Germany at CES 2022 – Advancing Digital Living
- 13 December 2021 - Merck KGaA, Darmstadt, Germany and SKKU Institute of Quantum Biophysics Sign MoU for Scientific Collaboration
- 14 December 2021 - First Vaccine Production Facility in Nigeria
- 17 December 2021 - Tepmetko receives positive CHMP opinion
- 29 December 2021 - Government Contract Award for New Lateral Flow Membrane Production Facility

January
- 06 January 2020 - Bavencio Bladder 100
- 09 January 2020 - Bonds
- 27 January 2020 - Merck KGaA, Darmstadt, Germany Invests in State-Of-The-Art Biotech Development Facility in Switzerland
- 30 January 2020 - Merck KGaA, Darmstadt, Germany Donates one Billionth Praziquantel Tablet
February
- 09 February 2020 - Hybrid 2020
- 11 February 2020 - Merck KGaA, Darmstadt, Germany’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D
- 18 February 2020 - Merck KGaA, Darmstadt, Germany to Manufacture Elypta’s Liquid Biopsy Kit
March
- 03 March 2020 - Merck KGaA, Darmstadt, Germany’s New LANEXO™ System to Improve Scientists’ Productivity in the Lab
- 05 March 2020 - Q4 2019
- 13 March 2020 - Bavencio Head and Neck
- 16 March 2020 - AGM Announcement
- 16 March 2020 - Ronastar® Dazzling Lights – new pigment by Merck
- 18 March 2020 - Clinicaltrials Update Company Statement
- 19 March 2020 - Merck KGaA, Darmstadt, Germany statement on Rebif (interferon beta-1a) donation to INSERM
- 25 March 2020 - Tepotinib
- 27 March 2020 - RonaCare® Balmance Restores Harmony to the Skin
- 27 March 2020 - Live Cosmetics Conference
- 27 March 2020 - Allergopharma Closing
April
- 02 April 2020 - Merck KGaA, Darmstadt, Germany Donates 150,000 Liters of Disinfectant to the State of Hesse
- 07 April 2020 - Merck KGaA, Darmstadt, Germany statement on Rebif® (interferon beta-1a) donation to the World Health Organization
- 07 April 2020 - Second U.S. Patent for CRISPR Gene-Editing Technology
- 09 April 2020 - 1L UC Submission and BTD
- 14 April 2020 - Merck KGaA, Darmstadt, Germany Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing
- 17 April 2020 - Merck KGaA, Darmstadt, Germany is Supporting Darmstadt in the Covid-19 Crisis
- 21 April 2020 - Merck KGaA, Darmstadt, Germany Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity
- 23 April 2020 - Ronastar® Blue Lights – Merck’s new interference pigment
- 24 April 2020 - Merck KGaA, Darmstadt, Germany Acquires OLED Patents for Display Applications from Konica Minolta
- 28 April 2020 - Merck KGaA, Darmstadt, Germany To Hold Virtual Annual General Meeting On May 28
- 30 April 2020 - ASCO 2020 Curtain Raiser
- 30 April 2020 - Merck KGaA, Darmstadt, Germany Accelerates Readiness of Bioprocessing Facility of the Future
May
- 06 May 2020 - China Seed Fund Investment
- 11 May 2020 - Merck KGaA, Darmstadt, Germany Granted U.S. Patents for Foundational CRISPR-Cas9 Technology
- 12 May 2020 - Move-Masks-Donation
- 13 May 2020 - ASCO 2020
- 14 May 2020 - Q1/2020: Quarterly Statement
- 23 May 2020 - New Late Breaking Data at EAN Evobrutinib
- 27 May 2020 - Merck and Baylor College of Medicine Collaborate
- 28 May 2020 - AGM 2020 - Annual General Meeting Approves Dividend Proposal
- 28 May 2020 - Joined Forces on World MS Day
- 29 May 2020 - New England Journal of Medicine Publishes Primary Analysis of VISION Data for Tepotinib
June
- 02 June 2020 - Merck KGaA, Darmstadt, Germany Announces Go-Live of Newly Integrated Performance Materials Organization
- 03 June 2020 - Merck KGaA, Darmstadt, Germany supports Cosmetics customers through second “Live Cosmetics Conference”
- 09 June 2020 - Strategic Partnership with Guardian Glass
- 10 June 2020 - Powerful New Option for CRISPR Research
- 22 June 2020 - European Medicines Agency Validates Application for BAVENCIO® (avelumab)
- 23 June 2020 - Startup from Merck KGaA, Darmstadt, Germany Innovation Lab in Israel Markets First Predictive Maintenance Sensors
- 25 June 2020 - First Clinical Trial of TLR7 and 8 Inhibitor as a Potential Treatment for Severe Symptoms
- 30 June 2020 - FDA Approves BAVENCIO® (avelumab) as First-Line Maintenance Treatment for Patients
July
- 01 July 2020 - Merck KGaA, Darmstadt, Germany Advances in Bioprocessing with Raman Technology Sensor Acquisition
- 01 July 2020 - New Report Identifies Paths to Pandemic Resilience
- 01 July 2020 - EU-Commission Supplementary Statement of Objections
- 02 July 2020 - Merck KGaA, Darmstadt, Germany to Develop Automated Diagnostic Tool together with Janssen
- 06 July 2020 - Merck KGaA, Darmstadt, Germany Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant
- 10 July 2020 - Opening of Life Science Business’ Largest M Lab™ Collaboration Center in Shanghai
- 13 July 2020 - Changes Executive Board
- 13 July 2020 - 3D Printing of Tablets
- 13 July 2020 - Stephan Sieber awarded € 1 million Future Insight Prize 2020
- 15 July 2020 - Merck KGaA, Darmstadt, GermanyInvests € 18 Million in New Life Science Laboratory in Switzerland
- 22 July 2020 - Performance Materials Launches € 100,000 Community Involvement Initiative
- 30 July 2020 - Merck KGaA, Darmstadt, Germany’s DOZN™ Green Chemistry Tool Named Top Project of the Year
- 31 July 2020 - Bavencio-UK-NICE
August
- 05 August 2020 - Statement on Rebif® (interferon beta-1a) contribution to the US National Institute of Allergy and Infectious Diseases for the ACTT 3 trial
- 06 August 2020 - Leadership Change within Group Communications at Merck KGaA, Darmstadt, Germany
- 06 August 2020 - Second Quarter: Merck KGaA, Darmstadt, Germany Remains on Course in a Challenging Environment
- 25 August 2020 - Tepotinib File Acceptance FDA 25-08-2020
September
- 03 September 2020 - New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting
- 09 September 2020 - Merck KGaA, Darmstadt, Germany Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion
- 10 September 2020 - Positive Phase II Results for Investigational Sonelokimab (M1095)
- 14 September 2020 - ESMO 2020 Curtain Raiser
- 16 September 2020 - Merck KGaA, Darmstadt, Germany Well-Positioned for Further Growth
- 18 September 2020 - Bavencio-Bladder-100-NEJM-ESMO
- 21 September 2020 - Merck KGaA, Darmstadt, Germany Opens State-of-the-art Research Center for Electronic Applications in Darmstadt
- 28 September 2020 - Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021
- 29 September 2020 - Press Release as a Result of the Ad-hoc Announcement of September 29, 2020
October
- 06 October 2020 - Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis
- 08 October 2020 - Merck KGaA, Darmstadt, Germany Celebrates Topping-Out Ceremony for New Membrane Production Plant
- 12 October 2020 - Merck KGaA, Darmstadt, Germany Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA
- 13 October 2020 - New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies
- 15 October 2020 - Healthcare R&D Leadership
- 19 October 2020 - Merck KGaA, Darmstadt, Germany Awards Grant to Combined Therapeutics
- 22 October 2020 - Curious Mind Research Award 2020
- 28 October 2020 - 2020-10-28 Merck KGaA, Darmstadt, Germany Announces € 20 Million OLED Manufacturing Expansion in Korea and China
- 29 October 2020 - 2020-10-29 Merck KGaA, Darmstadt, Germany Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test
November
- 06 November 2020 - Merck KGaA, Darmstadt, Germany Plans to Build a New Electronics Technology Center in China
- 09 November 2020 - Merck KGaA, Darmstadt, Germany Announces Out-Licensing Agreement for Investigational Atacicept
- 10 November 2020 - Merck KGaA, Darmstadt, Germany’s Latest Technologies Earn Industry Recognition for Accelerating Bioproce
- 12 November 2020 - Merck KGaA, Darmstadt, Germany Reports Strong Third Quarter
- 12 November 2020 - Merck KGaA, Darmstadt, Germany Presents New Sustainability Strategy
- 16 November 2020 - Ronastar® Yellow Allure – Merck’s New Mass Tone Pigment for Matte and Luminous
- 26 November 2020 - Digitalization of Production: Merck KGaA, Darmstadt, Germany and Siemens Collaborate
- 26 November 2020 - Tepotinib EMA Validation
December
- 01 December 2020 - Merck KGaA, Darmstadt, Germany Announces Partnerships to Advance Materials for Flexible, Foldable and Rollable OLED
- 03 December 2020 - Changes in the leadership team of Performance Materials
- 03 December 2020 - Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
- 07 December 2020 - Merck KGaA, Darmstadt, Germany Expands Life Science Production Capacities in the United States
- 11 December 2020 - Bavencio CHMP
- 14 December 2020 - CES 2021

January
- 15 January 2019 - Best Social Media Award
- 16 January 2019 - Merck KGaA, Darmstadt, Germany Welcomes Ten New Startups to its Innovation Center
- 23 January 2019 - Tencent Partnership China
- 24 January 2019 - Vertex DNA PK Licensing
- 28 January 2019 - EM-Boards
- 30 January 2019 - US Patent Blockchain
February
- 02 February 2019 - Ecovadis-Rating
- 04 February 2019 - Merck KGaA, Darmstadt, Germany Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease
- 05 February 2019 - m7824
- 06 February 2019 - Merck KGaA, Darmstadt, Germany Named a Global Top Employer
- 06 February 2019 - Merck KGaA, Darmstadt, Germany to Expand US Biopharmaceutical R&D Facility
- 11 February 2019 - Bavencio-Inlyta-FDA-sBLA
- 16 February 2019 - ASCO
- 19 February 2019 - First U.S. Patent for Improved CRISPR Genome-Editing Method
- 25 February 2019 - Merck KGaA, Darmstadt, Germany at in-cosmetics 2019
- 27 February 2019 - Science and Skincare Industry Meet at 4th Merck KGaA, Darmstadt, Germany DermoCosmetics Forum
- 27 February 2019 - Versum
March
- 04 March 2019 - Merck KGaA, Darmstadt, Germany Awarded Canadian CRISPR Nickase Patent
- 05 March 2019 - Versum Open Letter
- 07 March 2019 - Q4/FY Results of 2018
- 08 March 2019 - European Medicines Agency Validates Application for BAVENCIO® Plus INLYTA®
- 12 March 2019 - Versum Preliminary Proxy Statement
- 12 March 2019 - Inspiration and Innovation: Merck presents at European Coatings Show 2019
- 14 March 2019 - Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology
- 18 March 2019 - Merck KGaA, Darmstadt, Germany’s Milli-Q® Connect - Water Purification with Cloud-based Technology
- 19 March 2019 - JAVELIN Ovarian PARP
- 19 March 2019 - Collaboration GenScript China
- 20 March 2019 - Merck KGaA, Darmstadt, Germany Opens First M Lab™ Collaboration Center in Europe
- 20 March 2019 - Agreement applicable to the Darmstadt site
- 25 March 2019 - First Short-Course Oral Treatment for RRMS in Switzerland
- 26 March 2019 - Versum
- 28 March 2019 - Merck KGaA, Darmstadt, Germany Invests in Expansion of Manufacturing Capacity for Biotech Medicines
- 29 March 2019 - Mavenclad
April
- 02 April 2019 - BioContinuum™ Platform Strategy to Deliver ‘ContiGuous’ Bioprocessing
- 04 April 2019 - Merck KGaA, Darmstadt, Germany Recognized with INTERPHEX Exhibitor Award for Best New Product
- 12 April 2019 - Versum Definitive Agreement
- 15 April 2019 - Merck KGaA, Darmstadt, Germany Publishes Corporate Responsibility Report for 2018
- 24 April 2019 - Merck KGaA, Darmstadt, Germany Introduces New Greener Solvent, Cyrene™
- 26 April 2019 - Merck KGaA, Darmstadt, Germany Presents Plans for Future Growth to Shareholders
- 26 April 2019 - Wolfgang Büchele Re-elected Supervisory Board Chairman
- 30 April 2019 - Mavenclad
May
- 02 May 2019 - ESA
- 06 May 2019 - IMI
- 09 May 2019 - Emanuel Merck KGaA, Darmstadt, Germany Lectureship 2019 Kitagawa
- 10 May 2019 - PPII Data Further Highlights Clinical Proof of Concept for Evobrutinib
- 14 May 2019 - Bavencio
- 14 May 2019 - Q1-2019
- 15 May 2019 - ASCO 2019
- 20 May 2019 - Merck KGaA, Darmstadt, Germany Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing
- 22 May 2019 - WHA Life Science
- 28 May 2019 - Pm Sandmann Weiland
- 30 May 2019 - Merck KGaA, Darmstadt, Germany Awards Grants to Biotechs
- 30 May 2019 - Pioneers New Effort to See MS from the Inside Out
June
- 03 June 2019 - Merck KGaA, Darmstadt, Germany Presents Updated Results for Investigational Therapy Tepotinib
- 04 June 2019 - Quantum Computing
- 05 June 2019 - Accelerator
- 06 June 2019 - Crystal Do
- 18 June 2019 - Bond Financing Rating
- 18 June 2019 - Versum Stockholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
- 20 June 2019 - Best Places to Work
- 24 June 2019 - Mavenclad
July
- 01 July 2019 - Merck KGaA, Darmstadt, Germany Places Bonds Amounting to € 2 Billion
- 09 July 2019 - Future Insight Prize
- 16 July 2019 - Embracing Carers Time Counts
- 18 July 2019 - Broad Institute
- 18 July 2019 - Intermolecular
August
- 05 August 2019 - UDC PR
- 06 August 2019 - Merck KGaA, Darmstadt, Germany Acquires BSSN Software to Accelerate Customers’ Digital Transformation
- 08 August 2019 - Q2-2019
- 19 August 2019 - Crispr Patents
- 28 August 2019 - ECTRIMS
September
- 04 September 2019 - Heinrich Emanuel Merck Award 2019
- 09 September 2019 - WCLC 2019 Tepotinib
- 10 September 2019 - Evobrutinib
- 11 September 2019 - Tepotinib Breakthrough Therapy Designation
- 11 September 2019 - Capital Markets Day 2019
- 11 September 2019 - Capital Markets Day 2019 Update
- 20 September 2019 - Bavencio-RCC-CHMP
- 20 September 2019 - Intermolecular
- 23 September 2019 - ESMO19 Curtain Raiser
- 24 September 2019 - Women with Cancer
- 27 September 2019 - Erbitux 1L Approval in China
- 27 September 2019 - ESMO Bavencio
October
- 04 October 2019 - Schistosomiasis
- 07 October 2019 - Pigment Innovations at K2019
- 07 October 2019 - Versum Closing
- 08 October 2019 - JAMA Publication of Phase II Results of Sprifermin
- 08 October 2019 - Merck KGaA, Darmstadt, Germany Expands and Modernizes Pigments Production
- 10 October 2019 - Merck KGaA, Darmstadt, Germany Becomes the First to Use Acoustic Technology for Cell Therapy
- 18 October 2019 - Innovation Center Shanghai
- 22 October 2019 - Bavencio-MCC
- 28 October 2019 - Bavencio-RCC-EC-Approval
- 29 October 2019 - Curious Mind Researcher Award Granted
November
- 08 November 2019 - Bavencio Update JavelinGastric100
- 12 November 2019 - Merck KGaA, Darmstadt, Germany Licenses CRISPR Gene-Editing Technology to Evotec
- 14 November 2019 - Merck KGaA, Darmstadt, Germany Generates Profitable Growth in Q3 2019
- 18 November 2019 - Merck KGaA, Darmstadt, Germany Wins R&D 100 Award for First-to-Market Biopharma Purification Innovation
- 20 November 2019 - Merck KGaA, Darmstadt, Germany Announces Orphan Drug Designation for Investigational Therapy
- 26 November 2019 - Japan and Singapore Grant CRISPR Patents to Merck KGaA, Darmstadt, Germany
December
- 16 December 2019 - Consumer Electronics Show 2020
- 19 December 2019 - CRISPR license to Promega

January
- 16 January 2018 - ASCO GI Curtain Raiser
- 26 January 2018 - New Chief Information Officer
February
- 01 February 2018 - Researching New Highly Efficient OLEDs with Quantum Materials
- 05 February 2018 - Displaying-Futures-Award
- 05 February 2018 - 350th Anniversary
- 08 February 2018 - Merck KGaA, Darmstadt, Germany Plans 350 Good Deeds for its Anniversary Year
- 13 February 2018 - Merck KGaA, Darmstadt, Germany Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor
- 15 February 2018 - Update on Phase III JAVELIN Lung
- 16 February 2018 - Merck KGaA, Darmstadt, Germany named one of the global top employers in 2018
- 20 February 2018 - ExploreBio
- 20 February 2018 - Two Patents for CRISPR
- 21 February 2018 - 40 mn investment Asia
- 22 February 2018 - Nine new signature partnerships
- 23 February 2018 - Bavencio NOC
- 26 February 2018 - MAVENCLAD receives first approval in Latin America
- 28 February 2018 - Merck KGaA, Darmstadt, Germany Furthers Scientists' Research Through Expanded Seeding Labs Partnerhship
March
- 06 March 2018 - Evobrutinib in Relapsing Multiple Sclerosis
- 08 March 2018 - Q4/FY Results of 2017
- 13 March 2018 - Merck KGaA, Darmstadt, Germany Announces Changes to Performance Materials Leadership Team
- 19 March 2018 - Merck KGaA, Darmstadt, Germany Lights Up Luminale 2018 in Frankfurt with Innovative Art Installation
- 27 March 2018 - Fast-Track Designation for Tepotinib
- 27 March 2018 - Medisafe partnership
April
- 09 April 2018 - Mavenclad Receives First Approval in the Middle East & African Region
- 12 April 2018 - Merck KGaA, Darmstadt, Germany Helps Accelerate Access to Affordable Vaccines
- 13 April 2018 - Advance Multiple Sclerosis Treatment with MAVENCLAD and REBIF Data at AAN 2018
- 17 April 2018 - New single use technologies to advance flexible manufacturing
- 17 April 2018 - OARSI Curtain Raiser
- 18 April 2018 - Merck KGaA, Darmstadt, Germany Wins INTERPHEX Exhibitor Award for Best Technological Innovation
- 19 April 2018 - Consumer Health Divestiture
- 19 April 2018 - Partnership-UCT-MMV
- 23 April 2018 - Patent for CRISPR technology in China
- 27 April 2018 - Annual General Meeting 2018
- 27 April 2018 - Annual General Meeting 2018 Part 2
- 27 April 2018 - Merck KGaA, Darmstadt, Germany Advances Cell Analysis with New Benchtop Flow Cytometer
May
- 02 May 2018 - Mavenclad Data in MS Journal Show an Even Greater Treatment Effect in Patients
- 02 May 2018 - Corporate Responsibility Report Documents Comprehensive Engagement
- 02 May 2018 - Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group
- 03 May 2018 - Ceremony 350
- 14 May 2018 - New Liquid Crystal Singles by Merck on the SID 2018
- 15 May 2018 - Q1 - 2018
- 16 May 2018 - Merck to Use Genome Editing in Study of Gut Bacteria
- 16 May 2018 - Merck KGaA, Darmstadt, Germany data at ASCO 2018 to showcase progress and further optionality of oncology pipeline
- 22 May 2018 - Merck KGaA, Darmstadt, Germany Survey Reveals Most Thyroid Disorder Patients Find Road
- 22 May 2018 - Merck KGaA, Darmstadt, Germany Ignites Firework of Research Initiatives
- 28 May 2018 - Digital Color Card App: Effect Pigments Go Digital
- 29 May 2018 - Merck KGaA, Darmstadt, Germany Announces Collaboration with Solvias
- 30 May 2018 - World MS Day 2018: Call for Greater Curiosity to Drive Understanding of the Disease and Future Innovation
June
- 03 June 2018 - Merck KGaA, Darmstadt, Germany Presents Update on Tepotinib in Advanced Lung Cancer at ASCO 2018
- 04 June 2018 - Update Javelin Merkel 200 Bavencio
- 04 June 2018 - Merck KGaA, Darmstadt, Germany Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018
- 05 June 2018 - Bringing Biotechs Closer
- 06 June 2018 - Merck KGaA, Darmstadt, Germany Enhances Research and Capacity in Ghana for Malaria Prevention
- 06 June 2018 - Final Registration REACH
- 11 June 2018 - Update on Tepotinib Phase II Results
- 12 June 2018 - Thought Leadership in Ethical Gene Editing
- 12 June 2018 - Merck KGaA, Darmstadt, Germany Selects Three Winning Teams for Displaying Futures Award
- 14 June 2018 - Merck KGaA, Darmstadt, Germany to present data on Mavenclad® and Rebif® in RMS at EAN
- 18 June 2018 - Data Provide Further Insight into the Consistent Efficacy Benefits of Mavenclad
- 19 June 2018 - Agreement with HistoCyte Laboratories
- 20 June 2018 - China Celebration 350
- 20 June 2018 - OLED Lab China
July
- 03 July 2018 - Performance Materials Strategy Update
- 17 July 2018 - Merck KGaA, Darmstadt, Germany Announces Future Insight Prize
- 26 July 2018 - Merck KGaA, Darmstadt, Germany and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug
- 26 July 2018 - Merck KGaA, Darmstadt, Germany Euthyrox recommendation approval for reformulation in 21 EU countries
- 30 July 2018 - CladribineTablets FDA filing acceptance
August
- 09 August 2018 - GL Changes
- 09 August 2018 - Q2 - 2018
- 15 August 2018 - Merck KGaA, Darmstadt, Germany Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing
- 23 August 2018 - Wenzel to Lead the Surface Solutions
September
- 03 September 2018 - Ronastar Black Allure Merck introduces the next new luminous matte pigment
- 04 September 2018 - Next generation process intensification technologies to speed drug development
- 10 September 2018 - New Application Labs in Philadelphia Enable Close Collaboration
- 11 September 2018 - Positive Phase-III-Studie Bavencio plus Inlyta
- 14 September 2018 - Merck KGaA, Darmstadt, Germany Presents Interdisciplinary Cosmetics Research at IFSCC Congress 2018
- 21 September 2018 - Merck KGaA, Darmstadt, Germany Makes Major Investment in New Singapore Laboratory
October
- 02 October 2018 - Merck KGaA, Darmstadt, Germany Announces $3,000 Grand Prize Winner of Alfred R. Bader Award for Student
- 04 October 2018 - Merck KGaA, Darmstadt, Germany Opens M Lab™ Collaboration Center in São Paulo, Brazil
- 08 October 2018 - New Efficacy and Safety Data on MS Portfolio to be Presented at ECTRIMS 2018
- 09 October 2018 - ESMO Curtain Raiser
- 10 October 2018 - Up to 10-Years of Follow-up Data Reaffirm Safety Profile of Mavenclad
- 11 October 2018 - Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis
- 12 October 2018 - Merck KGaA, Darmstadt, Germany Recognized with CPhI Awards for Innovative Products
- 12 October 2018 - Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy
- 16 October 2018 - Merck KGaA, Darmstadt, Germany Aims to Return to Profitable Growth as of 2019
- 17 October 2018 - Merck KGaA, Darmstadt, Germany Inaugurates State-of-the-art Pharma Packaging Center in Darmstadt
- 18 October 2018 - Merck KGaA, Darmstadt, Germany Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Technologies
- 22 October 2018 - Merck KGaA, Darmstadt, Germany Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO
- 23 October 2018 - Merck KGaA, Darmstadt, Germany unveils new product brand eyrise™ at Glasstec 2018
- 30 October 2018 - Merck KGaA, Darmstadt, Germany Presents First Curious Mind Researcher Award
November
- 05 November 2018 - Embracing CarersTM expands support for carers worldwide
- 05 November 2018 - Merck KGaA, Darmstadt, Germany Launches BioContinuum™ Platform for Next-Generation Process Improvements
- 06 November 2018 - Merck KGaA, Darmstadt, Germany Debuts at First China International Import Expo
- 12 November 2018 - Merck KGaA, Darmstadt, Germany Paves the Way for its Innovation Hub in Southern China
- 14 November 2018 - Q3 - 2018
- 19 November 2018 - Winners of 2018 Life Science Awards
- 19 November 2018 - JAVELIN Ovarian 200
- 19 November 2018 - Syntropy
- 20 November 2018 - Access to Medicine Index 2018
- 23 November 2018 - Change II at ESMO Asia
- 23 November 2018 - MVentures
- 27 November 2018 - Merck KGaA, Darmstadt, Germany Wins Two R&D 100 Awards for Innovation in 2018
- 28 November 2018 - Euroshareholders Award 2018
December
- 01 December 2018 - Merck KGaA, Darmstadt, Germany successfully divests Consumer Health
- 03 December 2018 - Merck KGaA, Darmstadt, Germany Marks Fifth Anniversary of MDM Shanghai
- 06 December 2018 - Merck KGaA, Darmstadt, Germany in Agreement with Cyclica for AI-augmented Screening Platform to Expand Research Capabilities
- 06 December 2018 - Merck KGaA, Darmstadt, Germany Enables Innovations
- 10 December 2018 - Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation
- 10 December 2018 - CRISPR strategic Alliance
- 13 December 2018 - Merck KGaA, Darmstadt, Germany to Showcase Innovative Architectural Solutions at BAU 2019
- 20 December 2018 - Kuraray collaboration
- 20 December 2018 - M7824 ODD EMA
- 20 December 2018 - Intrexon
- 21 December 2018 - JAVELIN Ovarian 100
- 21 December 2018 - Price Increase Surface Solutions

January
- 09 January 2017 - Merck KGaA, Darmstadt, Germany and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration
- 10 January 2017 - Merck KGaA, Darmstadt, Germany Expands End-to-End Biodevelopment Centers in North America, China and ...
- 10 January 2017 - Merck KGaA, Darmstadt, Germany and CLEARink Displays Sign Development Agreement
- 11 January 2017 - Merck KGaA, Darmstadt, Germany Licenses Four Oncology Research and Development Programs from Vertex ...
- 12 January 2017 - Merck KGaA, Darmstadt, Germany Drives Business Opportunities in the U.S. to Foster Innovation Across..
- 12 January 2017 - Merck KGaA, Darmstadt, Germany Drives Business Opportunities in the U.S. to Foster Innovation...
- 12 January 2017 - Merck KGaA, Darmstadt, Germany and Palantir Launch New Healthcare Acceleration Partnership
- 17 January 2017 - Merck KGaA, Darmstadt, Germany Opens Production Facility Exclusively for Meglumine in Spain
- 17 January 2017 - Merck KGaA, Darmstadt, Germany Moves Executives Between Businesses and Group Functions
- 18 January 2017 - Merck KGaA, Darmstadt, Germany Launches First Commercial Screening Service to Predict Multiple Source
- 19 January 2017 - Innovation Award for Organic Photovoltaics at the BAU 2017
- 23 January 2017 - Merck KGaA, Darmstadt, Germany Announces Emerging Biotech Grant Program Winners
February
- 02 February 2017 - Merck KGaA, Darmstadt, Germany appoints Anke Schenkel as Head of Group Controlling & Risk Management
- 09 February 2017 - Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with...
- 28 February 2017 - FDA Accepts the Biologics License Application for Avelumab for the Treatment
March
- 02 March 2017 - Allergopharma Opens new Biopharmaceutical Production in Reinbek
- 09 March 2017 - Merck KGaA, Darmstadt, Germany Generates Record Sales and Continues to Grow Profitably in 2016
- 16 March 2017 - Merck KGaA, Darmstadt, Germany Presents Special Effect Products and Concepts at in-cosmetics 2017
- 22 March 2017 - “Bold & Vibrant”: Merck Presents Innovations at the European Coatings Show 2017
- 23 March 2017 - FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved
- 30 March 2017 - Merck KGaA, Darmstadt, Germany Advances R&D Strategy through Unique Development Model with Avillion for...
April
- 06 April 2017 - New Full Spectrum (FS) Phosphors: Merck Presents Brand-New Phosphor for Violet
- 12 April 2017 - EU Horizon 2020 Project “HyperOLED” Successfully Launched
- 18 April 2017 - Merck KGaA, Darmstadt, Germany Furthers Commitment Towards Elimination of Schistosomiasis Through Public
- 24 April 2017 - Merck KGaA, Darmstadt, Germany Divests Biosimilars Business to Fresenius
- 28 April 2017 - Annual General Meeting of Merck Approves Dividend Increase
- 28 April 2017 - Merck KGaA, Darmstadt, Germany is a company driven by a passion for research and discovery
May
- 02 May 2017 - Schmid Rhyner AG cooperation on 3D technology for printing with depth effect
- 08 May 2017 - Merck KGaA, Darmstadt, Germany at SID Conference: Future-oriented Materials for Displays and More
- 09 May 2017 - Acquire Grzybowski Scientific Inventions to Expand Chemical Synthesis Offering
- 09 May 2017 - FDA Grants Bavencio® approval for a common type of advanced bladder cancer
- 12 May 2017 - Merck KGaA, Darmstadt, Germany Opens First Joint Bioprocess Scale-up Lab with Stelis Biopharma in India
- 15 May 2017 - Industry’s First Off-the-Shelf Cell Culture Media for Perfusion Processes
- 16 May 2017 - Merck KGaA, Darmstadt, Germany’s CHOZN® Expression System Selected for Bi-specific Antibody Development
- 16 May 2017 - Optimizing the Further Development of the Darmstadt Site
- 17 May 2017 - Merck KGaA, Darmstadt, Germany Develops Alternative CRISPR Genome Editing Method
- 17 May 2017 - Shaping Cancer Care Today and Tomorrow: Merck KGaA, Darmstadt, Germany at ASCO 2017
- 18 May 2017 - Collaboration with the University of Leeds for New Optical Applications
- 31 May 2017 - Anyone Can Become More Curious. Is That True?
June
- 04 June 2017 - Immuno-oncology strengthening through expansion of F-star collaboration
- 14 June 2017 - Merck KGaA, Darmstadt, Germany Awarded its First CRISPR Patent by Australian Patent Office
- 15 June 2017 - Expand Distribution Agreement with Public Health England
- 20 June 2017 - Merck KGaA, Darmstadt, Germany Ventures Creates New Immuno-Oncology Company iOnctura
- 22 June 2017 - Merck KGaA, Darmstadt, Germany Foundation Established
- 22 June 2017 - Pigment Innovation at the Laser World of Photonics 2017
- 22 June 2017 - Cladribine Tablets Receives Positive CHMP Opinion
- 26 June 2017 - Merck KGaA, Darmstadt, Germany adds Chemical Products to Reaxys’ Chemistry Database
- 26 June 2017 - Merck KGaA, Darmstadt, Germany Displaying Futures Award Attracts High Interest
- 29 June 2017 - Merck KGaA, Darmstadt, Germany and Industry Partners Create New Automotive Coating Effects
July
- 05 July 2017 - Merck KGaA, Darmstadt, Germany Awards its 2017 Grant for Fertility Innovation (GFI)
- 06 July 2017 - Merck KGaA, Darmstadt, Germany Biopharma Innovation Cup 2017
- 06 July 2017 - Merck KGaA, Darmstadt, Germany Response on European Commission Statement of Objections
- 12 July 2017 - Merck KGaA, Darmstadt, Germany Refines Western European Life Science Production Site Network
- 21 July 2017 - Avelumab
- 21 July 2017 - Merck KGaA, Darmstadt, Germany Opens New Application Laboratory in Shanghai
August
- 03 August 2017 - Executive Board Changes at Merck KGaA, Darmstadt, Germany
- 03 August 2017 - Advance Vaccine Development and Manufacturing for Neglected Diseases
- 03 August 2017 - Second-quarter results 2017
- 03 August 2017 - European Patent Office to Grant Merck KGaA, Darmstadt, Germany’s Patent Application
- 23 August 2017 - Merck KGaA, Darmstadt, Germany to Exhibit at the IAA for the First Time
- 23 August 2017 - Merck KGaA, Darmstadt, Germany Sets Up PMatX Incubator in Israel for Next-Generation Electronics
- 25 August 2017 - Mavenclad
- 31 August 2017 - ESMO 2017
- 31 August 2017 - Seoul-Biennale
September
- 01 September 2017 - Successful Closing of Biosimilars Transaction
- 01 September 2017 - HEM-Award-2017
- 05 September 2017 - Merck KGaA, Darmstadt, Germany Prepares Strategic Options for the Consumer Health Business
- 07 September 2017 - IAA
- 10 September 2017 - GOI Awards ESMO 2017
- 11 September 2017 - PM-A new head names Heidi Fagerholm
- 11 September 2017 - GOBDA-MOU-signin
- 12 September 2017 - Merck KGaA, Darmstadt, Germany Advances Immunology Pipeline with Evobrutinib
- 13 September 2017 - Merck KGaA, Darmstadt, Germany Expands Celonics Upstream Capabilities with Mobius®
- 14 September 2017 - IAA-Successful-Premiere
- 18 September 2017 - Recipients of the Grant for Growth Innovation 2017
- 21 September 2017 - Bavencio EC Approval
- 21 September 2017 - ISAL-Automotive-Lighting
- 25 September 2017 - Investors-Darling
- 27 September 2017 - Bavencio-Japan-Approval
- 28 September 2017 - Capital Markets Day 2017
October
- 03 October 2017 - Merck KGaA, Darmstadt, Germany Invests € 35 Million in its Italian Biotech Manufacturing Site of Bari
- 05 October 2017 - Global Initiative | News
- 11 October 2017 - New Life Science Center Burlington
- 17 October 2017 - Merck KGaA, Darmstadt, Germany Presents New Clinical Data at ACR/ARHP Annual Meeting
- 19 October 2017 - Carlsbad
- 20 October 2017 - Science Top Employer
- 20 October 2017 - Advanced Light Protection Award
- 24 October 2017 - Crispr Canada Patent
- 25 October 2017 - MS-in-Women-Report-Announcement
- 25 October 2017 - LC-Windows-Frost-Sullivan-Award
- 26 October 2017 - ECTRIMS 2017
November
- 01 November 2017 - Lupus Foundation of America collaboration with Merck KGaA, Darmstadt, Germany
- 04 November 2017 - Merck KGaA, Darmstadt, Germany Presents Late Breaking Clinical Data from Phase II Trial of Sprifermin
- 09 November 2017 - Third quarter of 2017
- 09 November 2017 - NICE Recommends Mavenclad
- 09 November 2017 - Displaying-Futures-Tokyo
- 17 November 2017 - Top Place to Work
- 28 November 2017 - JAVELIN Gastric 300 Study
- 30 November 2017 - Merck KGaA, Darmstadt, Germany Opens Production Facility for Liquid Crystal Window Modules
December
- 04 December 2017 - Merck KGaA, Darmstadt, Germany KGaA, Darmstadt, Germany’s Mavenclad Approved for Relapsing-Remitting MS in Canada
- 05 December 2017 - Merck Announces FDA 510(k) Clearance of Fertility Benchtop Incubator GeriTM
- 07 December 2017 - Mavenclad Approval Australia
- 12 December 2017 - Merck KGaA, Darmstadt, Germany Signs Distribution Agreement with Avanti® Polar Lipids
- 12 December 2017 - Allan Gabor Takes Over the Leadership of Merck KGaA, Darmstadt, Germany in China
- 13 December 2017 - New Partnership to Fight Schistosomiasis
- 15 December 2017 - Corporate Affairs Wicklandt
- 19 December 2017 - Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology
- 20 December 2017 - Collaboration with iCON™
- 20 December 2017 - Merck KGaA, Darmstadt, Germany Signs Commercial Supply Agreement for Viral Vector Manufacturing
- 21 December 2017 - Avelumab Breakthrough Designation RCC

January
- 04 January 2016 - Updated Digital Version of Periodic Table of the Elements
- 04 January 2016 - Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of...
- 07 January 2016 - Collaboration on New Liquid Biopsy Technology
- 19 January 2016 - Merck KGaA, Darmstadt, Germany Appoints New Executive Board Members
- 21 January 2016 - Merck KGaA, Darmstadt, Germany and BrandWatch Technologies Form Long-Term Partnership
- 27 January 2016 - Merck KGaA, Darmstadt, Germany Announces New Biopharma Heads for North America and China
February
- 10 February 2016 - Amazing Lighting Experiences with Merck Materials
- 15 February 2016 - Merck KGaA, Darmstadt, Germany Presents New Material Advancements for Next Generation Lithography
- 16 February 2016 - Karl-Ludwig Kley Receives Weizmann Award in the Sciences and Humanities
- 16 February 2016 - Merck KGaA, Darmstadt, Germany and Weizmann Institute Sign New Framework Agreement on Research Collabora
- 19 February 2016 - Merck KGaA, Darmstadt, Germany Team Wins European Prize for Sigma-Aldrich Acquisition Financing
March
- 02 March 2016 - Merck KGaA, Darmstadt, Germany Initiates Phase III Study of MSB11022, a Proposed Biosimilar of....
- 03 March 2016 - Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 i
- 03 March 2016 - Merck KGaA, Darmstadt, Germany and the European Molecular Biology Laboratory Announce Drug Discovery...
- 07 March 2016 - Merck KGaA, Darmstadt, Germany Launches Global Science Education Program to Inspire Future Scientists
- 07 March 2016 - Life Science Leader Merck Launches New Innovations at Pittcon 2016
- 08 March 2016 - Merck KGaA, Darmstadt, Germany Finishes Record Year 2015 Stronger
- 15 March 2016 - Photovoltaic Windows: Energy Efficient and Energy Generating
- 29 March 2016 - Merck KGaA, Darmstadt, Germany’s CRISPR Epigenetic Activator Named to The Scientist’s Top 10 Innovation
- 29 March 2016 - New Highlights at In-Cosmetics 2016
April
- 05 April 2016 - Merck KGaA, Darmstadt, Germany and Pfizer Announce First Patient Treated in Phase III Combination Study
- 14 April 2016 - Merck KGaA, Darmstadt, Germany to Present Data On Comparative Effectiveness of Rebif®
- 14 April 2016 - Merck KGaA, Darmstadt, Germany Responds to Legal Claims in the U.S.
- 14 April 2016 - Maya Martinez-Davis as Global Head of Oncology
- 19 April 2016 - Merck KGaA, Darmstadt, Germany Earns Accreditation for Quality Control of Culture Media
- 25 April 2016 - Merck KGaA, Darmstadt, Germany Wins European Investor Relations Awards
- 26 April 2016 - First Multi-use Disposable Sterile Connectors for Biopharma
- 27 April 2016 - New Merck KGaA, Darmstadt, Germany Products Bring Ease of Use to Single-Use
- 29 April 2016 - Merck KGaA, Darmstadt, Germany Annual General Meeting 2016: CEO Handover After Ten Successful Years
- 29 April 2016 - Annual General Meeting Approves Dividend Increase
May
June
July
August
- 01 August 2016 - Merck KGaA, Darmstadt, Germany and Nanoco Sign Agreement on Eco-Friendly Quantum Materials for Displays
- 01 August 2016 - Merck KGaA, Darmstadt, Germany to Provide Provantage® End-to-End Development and Manufacturing...
- 02 August 2016 - Merck KGaA, Darmstadt, Germany Invests € 15 million in Liquid Crystal Window Technology
- 03 August 2016 - Merck KGaA, Darmstadt, Germany Expands Portfolio of Certified Reference Materials for Applied...
- 04 August 2016 - Merck KGaA, Darmstadt, Germany Lifts Forecast Following Good Second Quarter
- 09 August 2016 - Merck KGaA, Darmstadt, Germany is Co-Creating the Cars of Tomorrow
- 23 August 2016 - Merck KGaA, Darmstadt, Germany-Tagore Award Granted in India
September
- 07 September 2016 - Merck KGaA, Darmstadt, Germany Opens New OLED Materials Production Plant in Darmstadt
- 08 September 2016 - Merck KGaA, Darmstadt, Germany Launches New Gene Editing Technology to Engineer Virus Resistant CHO...
- 12 September 2016 - Merck KGaA, Darmstadt, Germany Announces Recipients of the Grant for Growth Innovation 2016
- 12 September 2016 - Merck KGaA, Darmstadt, Germany Presents New Data on the Safety and Durable Efficacy of Cladribine Tablet
- 13 September 2016 - Merck KGaA, Darmstadt, Germany Lab Earns ISO Accreditation for Quality Control of Culture Media
- 13 September 2016 - Merck KGaA, Darmstadt, Germany Strengthens Display Materials R&D in China
- 14 September 2016 - Merck KGaA, Darmstadt, Germany, Joins DiViNe Consortium to Address Low Yield...
- 15 September 2016 - Merck KGaA, Darmstadt, Germany Announces 2016 Recipients of €1 Million Grant for Multiple Sclerosis
- 16 September 2016 - Merck KGaA, Darmstadt, Germany Presents New Data Examining Durable Efficacy
- 19 September 2016 - Merck KGaA, Darmstadt, Germany’s New Steritest™ Symbio Pump Accessories Enable Faster, Safer...
- 21 September 2016 - Merck KGaA, Darmstadt, Germany Invests over € 50 million in Flagship Pharmaceutical Packaging...
- 22 September 2016 - Merck KGaA, Darmstadt, Germany Presents Displaying Futures Award for the First Time
- 22 September 2016 - Merck KGaA, Darmstadt, Germany and the Royal Health Awareness Society Partner to Advance Women’s Health
- 23 September 2016 - Merck KGaA, Darmstadt, Germany Appoints Isabel De Paoli as Chief Strategy Officer
- 26 September 2016 - Merck KGaA, Darmstadt, Germany Launches Viresolve® Pro Shield H for More Robust, Economical...
- 28 September 2016 - Merck KGaA, Darmstadt, Germany to Present New Research Focused on Hard-to- Treat Cancers at ESMO 2016
- 30 September 2016 - Merck KGaA, Darmstadt, Germany Presents Its First Russian Literary Prize
October
- 05 October 2016 - Merck KGaA, Darmstadt, Germany’s Udit Batra Receives ‘CEO of the Year’ Award from CPhI Pharma
- 06 October 2016 - Merck KGaA, Darmstadt, Germany Defines Blue-Glow Purple as the Effect Color of 2017
- 06 October 2016 - Merck KGaA, Darmstadt, Germany Unveils New State-of-the-Art M Lab™ Collaboration Center in Korea
- 10 October 2016 - Merck KGaA, Darmstadt, Germany Announces Recipients of Third Annual €1 Million ‘Grant for Oncology
- 11 October 2016 - Merck KGaA, Darmstadt, Germany Publishes First International Curiosity Study
- 12 October 2016 - Plastics with 3D Effect: Merck KGaA, Darmstadt, Germanyand PolyOne Agree to Collaborate
- 13 October 2016 - Merck KGaA, Darmstadt, Germany Sets its Sights on 2018 and Outlines Future Strategic Roadmap
- 13 October 2016 - Merck KGaA, Darmstadt, Germany Introduces First Certified Spiking Solution® of Heavy Labeled Thyroglobul
- 17 October 2016 - Merck KGaA, Darmstadt, Germany Grants Rights to tutoProm™ Surface Coatings to durXtreme
- 17 October 2016 - Merck KGaA, Darmstadt, Germany Expands Biotech Production Capacity in Spain
- 18 October 2016 - Merck KGaA, Darmstadt, Germany Showcases Innovative Effect Pigments and Processes at K2016
- 19 October 2016 - Merck KGaA, Darmstadt, Germany Donates 500 Millionth Praziquantel Tablet
- 21 October 2016 - Merck KGaA, Darmstadt, Germany-Kakehashi Literature Prize Presented in Japan
- 28 October 2016 - Merck KGaA, Darmstadt, Germany Named as Top Employer by Science Magazine
- 31 October 2016 - European Medicines Agency Validates the Marketing Authorization Application
November
- 01 November 2016 - Merck KGaA, Darmstadt, Germany Partners with American Cancer Society to Address Cancer in Women
- 02 November 2016 - Merck KGaA, Darmstadt, Germany Presents Phase II Data on the Safety and Efficacy of Atacicept
- 04 November 2016 - Merck KGaA, Darmstadt, Germany Invests € 250 Million in Production Value Chain in China
- 07 November 2016 - Merck KGaA, Darmstadt, Germany and Idemitsu Sign Collaboration Agreement in the OLED Material Business
- 11 November 2016 - Merck KGaA, Darmstadt, Germany Wins R&D 100 Award for Top Invention
- 14 November 2016 - Merck KGaA, Darmstadt, Germany’s Phase IIb ADDRESS II Results Confirm Potential of Atacicept
- 14 November 2016 - Merck KGaA, Darmstadt, Germany Ranks Fourth in 2016 Access to Medicine Index
- 15 November 2016 - Merck KGaA, Darmstadt, Germany Raises Profit Forecast for 2016 Following Good Third Quarter
- 16 November 2016 - Jens Frahm and Franz Pischinger Inducted into the Hall of Fame of German
- 22 November 2016 - Frosty-brilliant Silver Shine: The Merck Pigment Innovation
- 30 November 2016 - Merck KGaA, Darmstadt, Germany Collaborates with Evotec for Faster Target Identification Solution
December
- 01 December 2016 - Merck KGaA, Darmstadt, Germany Expands Distribution Agreement with Roche
- 02 December 2016 - Merck KGaA, Darmstadt, Germany Launches Parteck® MXP Excipient for Increased Solubility
- 05 December 2016 - Ronastar® Red Allure: The elegant, matte pigment innovation from Merck KGaA, Darmstadt, Germany
- 05 December 2016 - Merck KGaA, Darmstadt, Germany KGaA, Darmstadt, Germany to Provide Provantage® End-to-End Services to Acticor Biotech SAS
- 08 December 2016 - Merck KGaA, Darmstadt, Germany Appoints Thomas Möller as new Head of External Communications
- 13 December 2016 - Merck KGaA, Darmstadt, Germany Presents Smart Liquid Crystal Windows at BAU 2017
- 15 December 2016 - Xirallic® NXT Cougar Red: The mysterious colorintense pigment innovation

January
- 14 January 2015 - Merck KGaA, Darmstadt, Germany, Positions itself with New Suprima® Quality Brand for High-Quality Effect Pigments
- 15 January 2015 - Merck KGaA, Darmstadt, Germany, Presents Liquid Crystal Window Technology at BAU 2015
- 30 January 2015 - Merck KGaA, Darmstadt, Germany, Announces Personnel Changes in Finance Function
February
March
- 03 March 2015 - Merck KGaA, Darmstadt, Germany Finishes Year of Key Strategic Moves with Record Figures
- 04 March 2015 - Employees of Merck KGaA, Darmstadt, Germany, Benefit From Company Success
- 17 March 2015 - Merck KGaA, Darmstadt, Germany Places U.S. Bond Amounting to US$ 4.0 Billion
- 21 March 2015 - Merck KGaA, Darmstadt, Germany Supports Schistosomiasis Education in Mozambique
- 22 March 2015 - Merck KGaA, Darmstadt, Germany, Wins 2015 German Industry Innovation Award
- 31 March 2015 - Innovations and Concepts with Added Value: Merck KGaA, Darmstadt, Germany at the in-cosmetics 2015 Trade Show
April
May
June
July
August
September
October
November
- 02 November 2015 Experts to Explore new Smart Materials at “Displaying Futures” Symposium
- 04 November 2015 Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer
- 04 November 2015 Merck KGaA, Darmstadt, Germany, Hosts Hall of Fame of German Research for the First Time
- 05 November 2015 Karl-Ludwig Kley Joins Verizon Board of Directors
- 06 November 2015 Merck KGaA, Darmstadt, Germany, Recognized for Digital Workplace Platform
- 06 November 2015 Merck KGaA, Darmstadt, Germany, Underscores Commitment to Equal Opportunity
- 10 November 2015 Merck KGaA, Darmstadt, Germany, Set to Complete Sigma-Aldrich Acquisition
- 12 November 2015 Merck KGaA, Darmstadt, Germany, Reports Jump in Earnings in Q3 2015
- 18 November 2015 Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
- 18 November 2015 Merck KGaA, Darmstadt, Germany, Completes Sigma-Aldrich Acquisition
- 20 November 2015 Merck KGaA, Darmstadt, Germany, Counts on Africa for Growth
- 25 November 2015 Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products
- 26 November 2015 Gray Modules: New Dimension in Organic Photovoltaics for Buildings
- 30 November 2015 Miraval® Cosmic Bronze – The Second Effect Pigment in the New Product Series from Merck KGaA, Darmstadt, Germany
December
- 07 December 2015 Merck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer
- 09 December 2015 Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers
- 10 December 2015 Merck KGaA, Darmstadt, Germany, Confident for 2016
- 14 December 2015 Merck KGaA, Darmstadt, Germany, Acquires Ormet Circuits
- 14 December 2015 Merck KGaA, Darmstadt, Germany, Helps Refugees in Lebanon
- 16 December 2015 MilliporeSigma Honored by R&D Magazine for Innovation
- 21 December 2015 Ronastar® Lapis Jewel – For Sparkling Deep Blue Cosmetics
- 22 December 2015 Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab

January
- 26 January 2014 - Merck KGaA, Darmstadt, Germany, CFO Matthias Zachert to Join Lanxess
- 28 January 2014 - New Appointments to Supervisory Bodies of E. Merck KG, Darmstadt, Germany
February
- 04 February 2014 - Karl-Ludwig Kley named Honorary Senator of the University of Freiburg
- 06 February 2014 - Merck KGaA, Darmstadt, Germany, announces increased acceptances and extends offer period for AZ Electronic Materials
- 06 February 2014 - Merck KGaA, Darmstadt, Germany, appoints new Heads of Legal and Auditing functions
- 14 February 2014 - Merck KGaA, Darmstadt, Germany, extends timeline for its offer for AZ Electronic Materials
- 20 February 2014 - Merck KGaA, Darmstadt, Germany, Appoints Simon Sturge as New Head of Biosimilars Unit
- 28 February 2014 - Merck KGaA, Darmstadt, Germany, extends timeline for its offer for AZ Electronic Materials
- 28 February 2014 - Merck KGaA, Darmstadt, Germany, Supervisory Board nominates candidates for new elections in May
March
April
- 07 April 2014 - Meoxal® Atacama Red completes Desert Colors line of aluminum pigments of Merck KGaA, Darmstadt, Germany
- 17 April 2014 - BMBF Project PrintOLED: Development of Printed Light-Emitting Diodes Successfully Concluded
- 18 April 2014 - Merck KGaA, Darmstadt, Germany, Extends Offer for AZ Electronic Materials to May 2
- 23 April 2014 - Merck KGaA, Darmstadt, Germany, Announces Winner of Second Tagore Award of Merck KGaA, Darmstadt, Germany in India
- 24 April 2014 - Merck KGaA, Darmstadt, Germany, Announces Positive Outcome of IIIb Study for Kuvan
- 30 April 2014 - Merck KGaA, Darmstadt, Germany, Receives Final Antitrust Clearance for AZ Takeover
- 30 April 2014 - Insect repellent active substance IR3535® from Merck KGaA, Darmstadt, Germany, given the go-ahead at EU level
May
June
July
August
September
- 01 September 2014 - New Merck KGaA, Darmstadt, Germany, Headquarters Starts Taking Shape
- 02 September 2014 - BMBF Project “Polytos2: Printed Organic Circuits and Memory” successfully completed
- 12 September 2014 - Merck KGaA, Darmstadt, Germany, Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer
- 15 September 2014 - EMD Millipore Recognized for Technologically Advanced Products by R&D Magazine
- 16 September 2014 - When Coatings Began to Shine
- 18 September 2014 - Merck KGaA, Darmstadt, Germany, Strengthens Executive Board
- 18 September 2014 - Merck KGaA, Darmstadt, Germany, on Track with Pharma Strategy; Pipeline Progress Announced
- 22 September 2014 - Merck KGaA, Darmstadt, Germany, to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry
- 30 September 2014 - Merck KGaA, Darmstadt, Germany, Launches "Proud to be an Original" Employee Campaign
October
- 21 October 2014 - EMD Millipore Introduces Three New Resins for its Chromabolt® Prepacked Chromatography Columns
- 21 October 2014 - EMD Millipore Introduces PureFlex™ Plus Single-Use Process Container Film for High-Volume Biopharmaceutical Applications
- 28 October 2014 - Merck KGaA, Darmstadt, Germany, Researcher Pohl Inducted into the Hall of Fame of German Research
- 31 October 2014 - Merck KGaA, Darmstadt, Germany, Lends Support in the Fight Against Ebola
November
- 03 November 2014 - EMD Millipore’s New SNAP i.d.® 2.0 System for Immunohistochemistry Minimizes Slide Handling
- 04 November 2014 - Merck KGaA, Darmstadt, Germany: Executive Board Member Oschmann Elected President of IFPMA
- 06 November 2014 - Merck KGaA, Darmstadt, Germany, Holds “Displaying Futures” Symposium in Shanghai
- 13 November 2014 - Merck KGaA, Darmstadt, Germany, Reports Strong Top-Line Growth in Q3
- 14 November 2014 - Team from Merck KGaA, Darmstadt, Germany receives the Meyer-Galow Prize for business chemistry: Liquid crystals for energy-efficient smartphones and tablets
- 17 November 2014 - Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
- 18 November 2014 - Merck KGaA, Darmstadt, Germany, Advances to Sixth Place in the 2014 Access to Medicine Index
- 25 November 2014 - Merck KGaA, Darmstadt, Germany, Commissions Biomass Energy Plant in India
- 28 November 2014 - Consumer Health Division of Merck KGaA, Darmstadt, Germany, Sparks Debate on Future of OTC Sector
December
- 03 December 2014 - Merck KGaA, Darmstadt, Germany, Joins “Together for Sustainability” Network
- 04 December 2014 - EMD Serono Awards Grant for Growth - Countdown for Accepting Applications
- 05 December 2014 - Sigma-Aldrich Shareholders Approve Merger With Merck KGaA, Darmstadt, Germany
- 08 December 2014 - Merck KGaA, Darmstadt, Germany Issues Euro Hybrid Bond Amounting to € 1.5 billion
- 23 December 2014 - Merck KGaA, Darmstadt, Germany Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich